MedPath

Benfotiamine

Generic Name
Benfotiamine
Drug Type
Small Molecule
Chemical Formula
C19H23N4O6PS
CAS Number
22457-89-2
Unique Ingredient Identifier
Y92OUS2H9B

Overview

Benfotiamine has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.

Background

Benfotiamine has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.

Indication

No indication information available.

Associated Conditions

  • Thiamine Deficiency

Clinical Trials

Phase 2
Completed
Posted: 2014/11/17
Sponsor:
Burke Medical Resear...
Phase 3
Posted: 2013/06/04
Sponsor:
Diabetes Schwerpunkt...
Phase 3
Completed
Posted: 2008/11/05
Sponsor:
Ruhr University of B...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath